Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $13.82M in the quarter ending June 30, 2025, with 186.01% growth. This brings the company's revenue in the last twelve months to $199.89M, up 1,218.82% year-over-year. In the year 2024, Stoke Therapeutics had annual revenue of $36.56M with 316.34% growth.

• Revenue (ttm): $199.89M
• Revenue Growth: +1,218.82%
• P/S Ratio: 6.74
• Revenue / Employee: $1,561,664
• Employees: 128
• Market Cap: 1.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.